BIOS Fund III QP, LP — SEC insider filings

SEC reporting owner CIK 1791916. 21 insider filings on record with FilingPulse; latest filed 2026-10-30.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2021-08-03 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ACTUATE THERAPEUTICS, INC. (ACTU)Director, 10% owner53 legs · 571,428 sh · $4,499,9966 legs · 49,998 sh · $424,98365
IN8BIO, INC. (INAB)10% owner79 legs · 1,873,685 sh · $3,606,447—24
Azitra Inc (AZTR)10% owner16 legs · 2,297,490 sh · $3,000,0003 legs · 669,317 sh24
COGNITION THERAPEUTICS INC (CGTX)Director, 10% owner89 legs · 1,587,064 sh · $1,941,965—7

Insider filings — BIOS Fund III QP, LP

FiledFormIssuerReported transactionsSource
2026-10-304ACTUATE THERAPEUTICS, INC. (ACTU)
jointly with BIOS Fund III, LP, BIOS Fund III NT, LP
Grant/award (A): 64,995 (derivative) @ $0 · Grant/award (A): 87,743 (derivative) @ $0 · Grant/award (A): 682,885 (derivative) @ $0 · Grant/award (A): 194,984 (derivative) @ $0 · Grant/award (A): 368,304 (derivative) @ $0 · Grant/award (A): 47,972 (derivative) @ $0 · +7 moreEDGAR
2025-06-304ACTUATE THERAPEUTICS, INC. (ACTU)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, BIOS Equity Partners III, LP
Purchase (P): 71,428 @ $7 · Purchase (P): 71,428 (derivative) @ $0EDGAR
2025-06-204COGNITION THERAPEUTICS INC (CGTX)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BP Directors, LP
Grant/award (A): 34,000 @ $0EDGAR
2025-05-074IN8BIO, INC. (INAB)
jointly with Kreis Leslie W., BIOS Fund III, LP, BIOS Fund III NT, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, BP Directors, LP, Bios Equity Partners, LP, Cavu Management, LP, Cavu Advisors, LLC
Purchase (P): 1,148,482 (derivative) · Other (J): 574,241 (derivative) · Other (J): 574,241 (derivative)EDGAR
2024-10-114IN8BIO, INC. (INAB)
jointly with Kreis Leslie W., BIOS Fund III, LP, BIOS Fund III NT, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, BP Directors, LP, Bios Equity Partners, LP, Cavu Management, LP, Cavu Advisors, LLC
Purchase (P): 709,040 (derivative) · Purchase (P): 709,040 (derivative) · Disposition to issuer (D): 574,241 (derivative) · Grant/award (A): 574,241 (derivative)EDGAR
2024-08-204/AACTUATE THERAPEUTICS, INC. (ACTU)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, BIOS Equity Partners III, LP
Sale (S): 5,314 @ $8 · Sale (S): 17,361 @ $8 · Sale (S): 2,324 @ $8EDGAR
2024-08-144ACTUATE THERAPEUTICS, INC. (ACTU)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, BIOS Equity Partners III, LP
Conversion (C): 884,427 · Purchase (P): 375,000 @ $8 · Purchase (P): 125,000 @ $8 · Conversion (C): 525,797 · Conversion (C): 307,538 · Conversion (C): 141,457 · +50 moreEDGAR
2024-08-144ACTUATE THERAPEUTICS, INC. (ACTU)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, BIOS Equity Partners III, LP
Holdings only — no transactions reportedEDGAR
2024-06-114COGNITION THERAPEUTICS INC (CGTX)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BP Directors, LP
Grant/award (A): 8,500 @ $0 · Grant/award (A): 8,500 (derivative) @ $0EDGAR
2023-12-144IN8BIO, INC.
jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Purchase (P): 574,241 (derivative) · Purchase (P): 574,241 (derivative) · Purchase (P): 574,241 (derivative)EDGAR
2023-11-134COGNITION THERAPEUTICS INC (CGTX)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BP Directors, LP
Grant/award (A): 500,095 @ $1.05EDGAR
2023-06-234Azitra Inc (AZTR)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Equity Partners III, LP, BIOS Azitra Co-Invest I, LP
Sale (S): 77,953 · Purchase (P): 197,701 · Purchase (P): 69,880 @ $5 · Conversion (C): 137,186 · Sale (S): 509,141 · Purchase (P): 1,291,258 · +27 moreEDGAR
2023-06-134COGNITION THERAPEUTICS INC (CGTX)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP
Grant/award (A): 6,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0EDGAR
2022-12-134IN8BIO, INC. (INAB)
jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Purchase (P): 9,214 @ $2.48 · Purchase (P): 57,052 @ $2.48 · Purchase (P): 8,735 @ $2.48EDGAR
2022-11-294COGNITION THERAPEUTICS INC (CGTX)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP
Purchase (P): 1,973 @ $2.65 · Purchase (P): 12,220 @ $2.65 · Purchase (P): 1,871 @ $2.65EDGAR
2022-11-174COGNITION THERAPEUTICS INC (CGTX)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP
Purchase (P): 8,722 @ $1.40 · Purchase (P): 54,009 @ $1.40 · Purchase (P): 8,269 @ $1.40EDGAR
2022-11-164COGNITION THERAPEUTICS INC (CGTX)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP
Purchase (P): 184,270 @ $1.20 · Purchase (P): 1,141,030 @ $1.20 · Purchase (P): 174,700 @ $1.20EDGAR
2022-09-294IN8BIO, INC. (INAB)
jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Purchase (P): 3,070 @ $2.02 · Purchase (P): 19,017 @ $2.02 · Purchase (P): 2,913 @ $2.02EDGAR
2022-08-174IN8BIO, INC. (INAB)
jointly with Kreis Leslie W., BIOS Fund II NT, LP, BIOS Fund II, LP, BIOS Incysus Co-Invest I, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, Cavu Management, LP, Cavu Advisors, LLC
Purchase (P): 217,891 @ $1.90 · Purchase (P): 1,349,218 @ $1.90 · Purchase (P): 206,575 @ $1.90EDGAR
2022-02-014/ACOGNITION THERAPEUTICS INC (CGTX)
jointly with BIOS Memory SPV I, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Fund III, LP, BIOS Fund III NT, LP
Conversion (C): 1,424,014EDGAR
2021-08-034IN8BIO, INC. (INAB)
jointly with Fletcher Aaron G.L., BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Conversion (C): 574,432 · Conversion (C): 1,876,624 · Conversion (C): 251,211 · Conversion (C): 997,433 · Conversion (C): 340,712 · Conversion (C): 2,225,316 · +8 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2021-07-14 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1791916 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs